Home
Conditions
Lymphatic Diseases

Clinical trial condition

Lymphatic Diseases

Explore clinical trials studying Lymphatic Diseases. Study availability and eligibility vary by location and protocol.

8,978 public trials 1,830 recruiting studies

Refine in advanced search Browse all conditions

Lymphatic Diseases trial results

Recruiting

Venetoclax as Consolidation in CLL Patients Treated With BTK Inhibitor Monotherapy

NCT06958705

Conditions: Chronic Disease, Chronic Lymphocytic Leukemia (CLL) / Small Lymphocytic Lymphoma (SLL), Disease Attributes, +14 more
Locations: Department of Haematology, the First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital Nanjing, Jiangsu, China

View Trial Details

Recruiting

Pediatric Orthopaedic Implant Safety & Efficacy

NCT05361980

Conditions: Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Deformity of Limb, +27 more
Locations: BC Children's Hospital Vancouver, British Columbia, Canada

View Trial Details

Recruiting

DETERMINE Trial Treatment Arm 02: Atezolizumab in Adult, Paediatric and Teenage/Young Adult Patients With Cancers With High Tumour Mutational Burden (TMB) or Microsatellite Instability-high (MSI-high) or Proven Constitutional Mismatch Repair Deficiency (CMMRD) Disposition

NCT05770102

Conditions: Cancer, Colonic Diseases, Colorectal Neoplasms, +37 more
Locations: Belfast City Hospital Belfast, United Kingdom

University Hospital Birmingham Birmingham, United Kingdom

Birmingham Children's Hospital Birmingham, United Kingdom

Bristol Royal Hospital for Children Bristol, United Kingdom

View all 27 locations

View Trial Details

Recruiting

Fitness and Lung Function Among Survivors of Heart Transplant, Leukemia and Infant BPD Through Exercise

NCT05025774

Conditions: Acute Lymphoblastic Leukemia, Behavior, Chronic Disease, +22 more
Locations: Masonic Cancer Center Minneapolis, Minnesota, United States

View Trial Details

Recruiting

DETERMINE Trial Treatment Arm 05: Vemurafenib in Combination With Cobimetinib in Adult Patients With BRAF Positive Cancers.

NCT05768178

Conditions: Adenocarcinoma, Adenocarcinoma, Papillary, Adnexal Diseases, +74 more
Locations: Belfast City Hospital Belfast, United Kingdom

University Hospital Birmingham Birmingham, United Kingdom

Bristol Haematology and Oncology Centre Bristol, United Kingdom

Addenbrooke's Hospital Cambridge, United Kingdom

View all 16 locations

View Trial Details

Recruiting

DETERMINE Trial Treatment Arm 03: Entrectinib in Adult, Paediatric and Teenage/Young Adult Patients With ROS1 Gene Fusion-Positive Cancers.

NCT05770544

Conditions: Brain Diseases, Brain Neoplasms, Cancer, +30 more
Locations: Belfast City Hospital Belfast, United Kingdom

University Hospital Birmingham Birmingham, United Kingdom

Birmingham Children's Hospital Birmingham, United Kingdom

Bristol Royal Hospital for Children Bristol, United Kingdom

View all 27 locations

View Trial Details

Recruiting

DETERMINE Trial Treatment Arm 01: Alectinib in Adult, Paediatric and Teenage/Young Adult Patients With ALK Positive Cancers

NCT05770037

Conditions: Adenocarcinoma, Anaplastic Large Cell Lymphoma, Cancer, +37 more
Locations: Belfast City Hospital Belfast, United Kingdom

University Hospital Birmingham Birmingham, United Kingdom

Birmingham Children's Hospital Birmingham, United Kingdom

Bristol Royal Hospital for Children Bristol, United Kingdom

View all 27 locations

View Trial Details

Recruiting

Study of the Medullary Microenvironment in Acute Childhood Leukemia

NCT05792007

Conditions: Acute Lymphoid Leukemia, Acute Myeloid Leukemia in Children, Hematologic Diseases, +10 more
Locations: Service d'hématologie biologique-CHRU TOURS Tours, France

Service d'onco-hématologie pédiatrique -CHRU Tours Tours, France

Service de chirurgie orthopédique pédiatrique -CHRU TOURS Tours, France

View Trial Details

Recruiting

Blinatumomab and Auto-HSCT Sandwich Strategy as Consolidation Therapy for B-ALL

NCT06507514

Conditions: B-cell Acute Lymphoblastic Leukemia, Burkitt Lymphoma, DNA Virus Infections, +15 more
Locations: The First Affliated Hospital of Soochow University Suzhou, Jiangsu, China

View Trial Details

Recruiting

Venetoclax With Ibrutinib or Acalabrutinib in Pts. With High-risk CLL

NCT03128879

Conditions: Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +14 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

View Trial Details

Lymphatic Diseases

Lymphatic Diseases trial results

Related conditions